Daniela Mazzaccaro

Dr. Daniela Mazzaccaro

Operative Unit of Vascular and Endovascular Surgery, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy
+1
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
IBIacopo Barbetta
Iacopo Barbetta
MCMichele Carmo
Michele Carmo
GMGiulio Mercandalli
Giulio Mercandalli
PLPatrizia Lattuada
Patrizia Lattuada
Daniela MazzaccaroDaniela Mazzaccaro
Daniela Mazzaccaro
PSPiergiorgio G. Settembrini
Piergiorgio G. Settembrini

1 December 2015 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
Daniela MazzaccaroDaniela Mazzaccaro
Daniela Mazzaccaro
MCMichele Carmo
Michele Carmo
RDRaffaello Dallatana
Raffaello Dallatana
Alberto SettembriniAlberto Settembrini
Alberto Settembrini
IBIacopo Barbetta
Iacopo Barbetta
PSPiergiorgio G. Settembrini
Piergiorgio G. Settembrini

Verified
Journal Article
Open access
PDF file
Daniela MazzaccaroDaniela Mazzaccaro
Daniela Mazzaccaro
FGFrancesca Giacomazzi
Francesca Giacomazzi
MGMatteo Giannetta
Matteo Giannetta
AVAlberto Varriale
Alberto Varriale
RSRosa Scaramuzzo
Rosa Scaramuzzo
GNGiovanni Nano
Giovanni Nano
Introduction: Aim of the study is to assess the occurrence of early stage coagulopathy and disseminated intravascular coagulation (DIC) in patients with mild to moderate respiratory distress secondary to SARS-CoV-2 infection. Materials and methods: Data of patients hospitalized from 18 March 2020 to 20 April 2020 were retrospectively reviewed. Two scores for the screening of coagulopathy (SIC and non-overt DIC scores) were calculated. The occurrence of thrombotic complication, death, and worsening respiratory function requiring non-invasive ventilation (NIV) or admission to ICU were recorded, and these outcomes were correlated with the results of each score. Chi-square test, receiver-operating characteristic curve, and logistic regression analysis were used as appropriate. p Values < 0.05 were considered statistically significant. Results: Data of 32 patients were analyzed. Overt-DIC was diagnosed in two patients (6.2%), while 26 (81.2%) met the criteria for non-overt DIC. Non-overt DIC score values ≥4 significantly correlated with the need of NIV/ICU (p = 0.02) and with the occurrence of thrombotic complications (p = 0.04). A score ≥4 was the optimal cut-off value, performing better than SIC score (p = 0.0018). Values ≥4 in patients with thrombotic complications were predictive of death (p = 0.03). Conclusions: Overt DIC occurred in 6.2% of non-ICU patients hospitalized for a mild to moderate COVID-19 respiratory distress, while 81.2% fulfilled the criteria for non-overt DIC. The non-overt DIC score performed better than the SIC score in predicting the need of NIV/ICU and the occurrence of thrombotic complications, as well as in predicting mortality in patients with thrombotic complications, with a score ≥4 being detected as the optimal cut-off.

1 August 2014 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
GNGiovanni Nano
Giovanni Nano
MOMaria T. Occhiuto
Maria T. Occhiuto
SSSilvia Stegher
Silvia Stegher
GMGiovanni Malacrida
Giovanni Malacrida
MCMarta Cova
Marta Cova
Daniela MazzaccaroDaniela Mazzaccaro
Daniela Mazzaccaro

17 April 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Daniela MazzaccaroDaniela Mazzaccaro
Daniela Mazzaccaro
PRPaolo Righini
Paolo Righini
FFFabiana Fancoli
Fabiana Fancoli
MGMatteo Giannetta
Matteo Giannetta
AMAlfredo Modafferi
Alfredo Modafferi
GNGiovanni Nano
Giovanni Nano
Blunt thoracic aortic injury (BTAI) is a potentially fatal condition that needs prompt recognition and expedited management. Clinical manifestations of BTAI are not straight forwarding and may be misdiagnosed. The grade of aortic injury is an important determinant of perioperative mortality and morbidity, as well as the indication of treatment, along with the presence of concomitant lesions of other involved organs. The mainstay of treatment nowadays for hemodynamically stable patients who survive the trauma scene is represented by delayed endovascular repair whenever anatomically and clinically feasible. Endovascular repair, in fact, is burdened by lower perioperative mortality and morbidity rates if compared to open surgical repair, but concerns remain about the need for long-term surveillance and radiation exposure in patients who are at a younger age than patients treated for the aneurysmal disease. The aim of the paper is to provide an update on the diagnostic modalities and strategies of treatment for patients affected by BTAI.

12 March 2014 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
GNGiovanni Nano
Giovanni Nano
Daniela MazzaccaroDaniela Mazzaccaro
Daniela Mazzaccaro
SSSilvia Stegher
Silvia Stegher
MOMaria Teresa Occhiuto
Maria Teresa Occhiuto
GMgiovanni agostino malacrida
giovanni agostino malacrida
PVPietro Volpe
Pietro Volpe
We describe our initial experience with the use of the TriVascular Ovation endograft system for the treatment of abdominal aortic aneurysms (AAA). We retrospectively reviewed data from patients treated for AAA using the Ovation endograft at two institutions from January 2011 to September 2012. Main outcomes included primary success, survival, complications, and device-related events. The mean follow-up period was 10 months (range 1-22 months). Thirty-seven patients (male: 95%, mean age: 76 yr) were treated for AAA (mean diameter: 54 mm) with the Ovation endograft. Local or regional anesthesia was used in 86.5% of cases. Percutaneous access was utilized in 73% of cases. Primary success was 89.2% (33/37). Four adjunctive procedures were required including two distal extensions (type 1b endoleak and iliac limb disconnection resulting in type III endoleak) and two bypass surgeries (limb graft occlusion and gate cannulation failure). No deaths or major complications were reported during the procedure or in follow-up. No type I, III, or IV endoleak, AAA enlargement, AAA rupture, stent fracture, migration, or endovascular or surgical reintervention were reported during the follow-up period. Type II endoleak was observed in two patients. Asymptomatic narrowing of both iliac limbs was observed in one patient at 6 months. Our initial experience with the Ovation endograft demonstrated encouraging results in patients with AAA.